Gemmer Asset Management LLC Neurocrine Biosciences Inc Transaction History

Gemmer Asset Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 19, 2021	SELL	$86.18 - $99.03 $3,533 - $4,060	-41 Closed	0 $0
Q2 2021 Jul 23, 2021	BUY	$89.43 - $102.27 $3,666 - $4,193	41 New	41 $4,000
Q4 2019 Jan 17, 2020	SELL	$86.8 - $118.57 $173 - $237	-2 Closed	0 $0
Q3 2019 Oct 11, 2019	BUY	$83.82 - $101.5 $167 - $203	2 New	2 $0

638

93.8M

632K

621K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $14.5B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Gemmer Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Gemmer Asset Management LLC with notifications on news.